PAWC
P.A.W. Capital Portfolio holdings
AUM
$51.9M
This Quarter Return
+3.67%
1 Year Return
+46.14%
3 Year Return
+74.13%
5 Year Return
+167.35%
10 Year Return
+839.74%
AUM
$97.3M
AUM Growth
-$2.41M
(-2.4%)
Cap. Flow
-$3.98M
Cap. Flow
% of AUM
-4.09%
Top 10 Holdings %
Top 10 Hldgs %
38.05%
Holding
75
New
4
Increased
20
Reduced
14
Closed
7
Top Buys
| 1 |
Garmin
GRMN
|
$3.08M |
| 2 |
Marchex
MCHX
|
$1.49M |
| 3 |
Allot
ALLT
|
$1.22M |
| 4 |
Qualcomm
QCOM
|
$940K |
| 5 |
Amgen
AMGN
|
$921K |
Top Sells
| 1 |
IGTE
IGATE CORPORATION
IGTE
|
$5.01M |
| 2 |
PKT
PROCERA NETWORKS INC NEW COM STK (DE)
PKT
|
$2.07M |
| 3 |
ORBK
Orbotech Ltd
ORBK
|
$1.46M |
| 4 |
Tapestry
TPR
|
$1.24M |
| 5 |
WEB
Web.com Group, Inc.
WEB
|
$1.21M |
Sector Composition
| 1 | Technology | 35.47% |
| 2 | Healthcare | 15.55% |
| 3 | Communication Services | 10.43% |
| 4 | Financials | 6.68% |
| 5 | Energy | 5.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
New Mountain Finance
NMFC
$1.12B
| $1.52M | 1.53% |
105,000
+9,000
| +9% | +$130K |
|
27
Digital Turbine
APPS
$455M
| $1.51M | 1.52% |
500,000
+100,000
| +25% | +$302K |
|
|
EXAR
28
DELISTED
Exar Corporation
EXAR
| $1.47M | 1.48% |
150,000
-80,000
| -35% | -$782K |
|
|
LJPC
29
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.35M | 1.36% |
55,000
+15,000
| +38% | +$368K |
|
|
ESRX
30
DELISTED
Express Scripts Holding Company
ESRX
| $1.33M | 1.35% |
15,000
| – | – |
|
|
LKM
31
DELISTED
Link Motion Inc.
LKM
| $1.06M | 1.07% |
200,000
-30,000
| -13% | -$158K |
|
|
BBBY
32
DELISTED
Bed Bath & Beyond Inc
BBBY
| $1.04M | 1.04% |
15,000
+5,000
| +50% | +$345K |
|
|
RKUS
33
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $1.03M | 1.04% |
100,000
+70,000
| +233% | +$724K |
|
|
SHOR
34
DELISTED
ShoreTel, Inc.
SHOR
| $1.02M | 1.03% |
150,000
+50,000
| +50% | +$339K |
|
35
Gilead Sciences
GILD
$140B
| $995K | 1% |
8,500
+1,500
| +21% | +$176K |
|
|
PLPM
36
DELISTED
Planet Payment, Inc
PLPM
| $968K | 0.98% |
400,000
| – | – |
|
|
37
Amgen
AMGN
$153B
| $921K | 0.93% |
+6,000
| New | +$921K |
|
38
Enphase Energy
ENPH
$4.76B
| $913K | 0.92% |
120,000
| – | – |
|
39
DuPont de Nemours
DD
$31.6B
| $768K | 0.77% |
7,435
| – | – |
|
40
Verastem
VSTM
$595M
| $754K | 0.76% |
8,333
+1,666
| +25% | +$151K |
|
41
AT&T
T
$209B
| $746K | 0.75% |
27,804
| – | – |
|
42
GE Aerospace
GE
$294B
| $744K | 0.75% |
5,843
| – | – |
|
43
Iovance Biotherapeutics
IOVA
$789M
| $734K | 0.74% |
80,000
+15,000
| +23% | +$138K |
|
44
Altria Group
MO
$113B
| $734K | 0.74% |
15,000
| – | – |
|
|
IGTE
45
DELISTED
IGATE CORPORATION
IGTE
| $715K | 0.72% |
15,000
-105,000
| -88% | -$5.01M |
|
46
Verizon
VZ
$186B
| $699K | 0.71% |
15,000
| – | – |
|
47
Abbott
ABT
$230B
| $687K | 0.69% |
14,000
| – | – |
|
48
Johnson & Johnson
JNJ
$429B
| $682K | 0.69% |
7,000
| – | – |
|
49
Philip Morris
PM
$254B
| $673K | 0.68% |
8,400
| – | – |
|
50
Pfizer
PFE
$140B
| $671K | 0.68% |
21,080
| – | – |
|